Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2010 2
2011 2
2012 5
2013 4
2014 9
2015 8
2016 12
2017 6
2018 8
2019 12
2020 11
2021 15
2022 15
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer.
Francis KE, Kim SI, Friedlander M, Gebski V, Ray-Coquard I, Clamp A, Penson RT, Oza A, Perri T, Huzarski T, Martin-Lorente C, Cecere SC, Colombo N, Ataseven B, Fujiwara K, Sonke G, Vergote I, Pujade-Lauraine E, Kim JW, Lee CK. Francis KE, et al. Among authors: ataseven b. Ann Oncol. 2022 Jun;33(6):593-601. doi: 10.1016/j.annonc.2022.02.222. Epub 2022 Feb 24. Ann Oncol. 2022. PMID: 35219776 Clinical Trial.
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study.
Trillsch F, Mahner S, Ataseven B, Asher R, Aryal N, Dubot C, Clamp A, Penson RT, Oza A, Amit A, Huzarski T, Casado A, Scambia G, Friedlander M, Colombo N, Fujiwara K, Sonke GS, Denys H, Lowe ES, Lee CK, Pujade-Lauraine E. Trillsch F, et al. Among authors: ataseven b. Gynecol Oncol. 2022 Apr;165(1):40-48. doi: 10.1016/j.ygyno.2022.01.024. Epub 2022 Jan 31. Gynecol Oncol. 2022. PMID: 35115180 Clinical Trial.
[Breast cancer].
Ataseven B, Eiermann W. Ataseven B, et al. Dtsch Med Wochenschr. 2006 May 12;131(19):1091-9; quiz 1101-2. doi: 10.1055/s-2006-941727. Dtsch Med Wochenschr. 2006. PMID: 16685631 Review. German. No abstract available.
Low-grade Serous Tumors: Are We Making Progress?
Pauly N, Ehmann S, Ricciardi E, Ataseven B, Bommert M, Heitz F, Prader S, Schneider S, du Bois A, Harter P, Baert T. Pauly N, et al. Among authors: ataseven b. Curr Oncol Rep. 2020 Jan 27;22(1):8. doi: 10.1007/s11912-020-0872-5. Curr Oncol Rep. 2020. PMID: 31989304 Review.
Some thoughts about surgery in ovarian cancer 2021.
du Bois A, Harter P, Ataseven B. du Bois A, et al. Among authors: ataseven b. Int J Gynecol Cancer. 2021 Nov;31(11):1492-1493. doi: 10.1136/ijgc-2021-002664. Int J Gynecol Cancer. 2021. PMID: 34725245 Review. No abstract available.
How to manage lymph nodes in ovarian cancer.
Harter P, Heitz F, Ataseven B, Schneider S, Baert T, Prader S, du Bois A. Harter P, et al. Among authors: ataseven b. Cancer. 2019 Dec 15;125 Suppl 24:4573-4577. doi: 10.1002/cncr.32514. Cancer. 2019. PMID: 31967675 Free article. Review.
Low-grade Serous Ovarian Carcinoma.
Ricciardi E, Baert T, Ataseven B, Heitz F, Prader S, Bommert M, Schneider S, du Bois A, Harter P. Ricciardi E, et al. Among authors: ataseven b. Geburtshilfe Frauenheilkd. 2018 Oct;78(10):972-976. doi: 10.1055/a-0717-5411. Epub 2018 Oct 19. Geburtshilfe Frauenheilkd. 2018. PMID: 30364401 Free PMC article.
101 results